Cited by 54Parasitic Diseases Research and TreatmentEpilepsy research and treatmentNeuroinflammation and Neurodegeneration Mechanisms

Neuroinflammation and not tauopathy is a predominant pathological signature of nodding syndrome.

Open access
Hotterbeekx, An, Lammens, Martin, Idro, Richard, Akun, Pamela R, Lukande, Robert, Akena, Geoffrey, Nath, Avindra, Taylor, Joneé +3 more·2019·Journal of Neuropathology & Experimental Neurology

Abstract

Nodding syndrome (NS) is an epileptic disorder occurring in children in African onchocerciasis endemic regions. Here, we describe the pathological changes in 9 individuals from northern Uganda who died with NS (n = 5) or other forms of onchocerciasis-associated epilepsy (OAE) (n = 4). Postmortem examinations were performed and clinical information was obtained. Formalin-fixed brain samples were stained by hematoxylin and eosin and immunohistochemistry was used to stain astrocytes (GFAP), macrophages (CD68), ubiquitin, α-synuclein, p62, TDP-43, amyloid β, and tau (AT8). The cerebellum showed atrophy and loss of Purkinje cells with hyperplasia of the Bergmann glia. Gliosis and features of past ventriculitis and/or meningitis were observed in all but 1 participant. CD68-positive macrophage clusters were observed in all cases in various degrees. Immunohistochemistry for amyloid β, α-synuclein, or TDP-43 was negative. Mild to sparse AT8-positive neurofibrillary tangle-like structures and threads were observed in 4/5 NS and 2/4 OAE cases, preferentially in the frontal and parietal cortex, thalamic- and hypothalamic regions, mesencephalon and corpus callosum. Persons who died with NS and other forms of OAE presented similar pathological changes but no generalized tauopathy, suggesting that NS and other forms of OAE are different clinical presentations of a same disease with a common etiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnen/nlz090

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • P-tau pathology is found in patients with temporal lobe epilepsy, Dravet syndrome, Nodding syndrome, Niemann-Pick type C disease, focal cortical dysplasia IIB, and tuberous sclerosis complex, as well as animal models of post-traumatic epilepsy, Lafora disease, and autism spectrum disorder.

    “These include patients with TLE, Dravet syndrome, Nodding syndrome (Thom et al., 2011; Pollanen et al., 2018; Hotterbeekx et al., 2019), Niemann-Pick type C disease (NPC) (Auer et al., 1995; Love et al., 1995; Suzuki et al., 1995; Malnar et al., 2014), focal cortical dysplasia IIB (FCDIIb) (Sen et al., 2007; Iyer et al., 2014), and tuberous sclerosis complex (TSC) (Sarnat and Flores-Sarnat, 2015;”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Hotterbeekx et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [1]Dowell SF, Sejvar JJ, Riek L, et al Nodding syndrome. Emerging Infect Dis 2013; 19: 1374– 84 23965548 PMC3810928
  2. [2]Sejvar JJ, Kakooza AM, Foltz JL, et al Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: An observational case series. Lancet Neurol 2013; 12: 166– 74 23305742
  3. [3]Colebunders R, Nelson Siewe FJ, Hotterbeekx A. Onchocerciasis-associated epilepsy, an additional reason for strengthening onchocerciasis elimination programs. Trends Parasitol 2018; 34: 208– 16 29288080
  4. [4]Idro R, Ogwang R, Kayongo E, et al The natural history of nodding syndrome. Epileptic Disord 2018; 20: 508– 16 30530420
  5. [5]Johnson TP, Tyagi R, Lee PR, et al Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus. Sci Transl Med 2017; 9: eaaf6953 28202777 PMC5434766
  6. [6]Pollanen MS, Onzivua S, Robertson J, et al Nodding syndrome in Uganda is a tauopathy. Acta Neuropathol 2018; 136: 691– 7 30219940 PMC6208726
  7. [7]Hissette J. Memoire sur l'Onchocerca volvulus ‘Lecart’ et ses manifestations oculaire au Congo Belge, Bulletin de l'association des médecins anciens étudiants de l'Université catholique de Louvain. 1932:24–8
  8. [8]Duke BO, Vincelette J, Moore PJ. Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed Parasitol 1976; 27: 123– 32 941247
  9. [9]Mazzotti L. Presencia de microfilarias de Onchocerca vulvulus en el liquido cefalorraquideo en enfermos tratados con hetrazan. revInstSaluburEnfermtrop (Mex) 1959; 19: 1– 5
  10. [10]Brattig NW. Pathogenesis and host responses in human onchocerciasis: Impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect 2004; 6: 113– 28 14738900
  11. [11]Saint Andre A, Blackwell NM, Hall LR, et al The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002; 295: 1892– 5 11884755
  12. [12]Winkler AS, Friedrich K, Velicheti S, et al MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: An observational study. Afr Health Sci 2013; 13: 529– 40 24235964 PMC3824510
  13. [13]Idro R, Opoka RO, Aanyu HT, et al Nodding syndrome in Ugandan children–clinical features, brain imaging and complications: A case series. BMJ Open 2013; 3: e002540. PMC3646179 23645924
  14. [14]Hotterbeekx A, Onzivua S, Menon S, et al Histological examination of post-mortem brains of children with nodding syndrome. Ann Transl Med 2018; 6: 134 29955594 PMC6015950
  15. [15]Wu JW, Hussaini SA, Bastille IM, et al Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 2016; 19: 1085– 92 27322420 PMC4961585
  16. [16]Santangelo R, Cecchetti G, Bernasconi MP, et al Cerebrospinal fluid amyloid-beta 42, total tau and phosphorylated tau are low in patients with normal pressure hydrocephalus: Analogies and differences with Alzheimer's disease. J Alzheimers Dis 2017; 60: 183– 200 28826180
  17. [17]Bancher C, Leitner H, Jellinger K, et al On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiol Aging 1996; 17: 527– 33 8832626
  18. [18]Wisniewski HM, Jerzy D, Jerzy W, et al Neurofibrillary pathology in subacute sclerosing panencephalitis. Dementia 1991; 2: 133– 41
  19. [19]Idro R, Musubire KA, Byamah Mutamba B, et al Proposed guidelines for the management of nodding syndrome. Afr Health Sci 2013; 13: 219– 32 24235917 PMC3824512
  20. [20]Zhao H, Collier JM, Quah DM, et al The modified Rankin Scale in acute stroke has good inter-rater-reliability but questionable validity. Cerebrovasc Dis 2010; 29: 188– 93 20029188
  21. [21]Colebunders R, Mandro M, Mokili JL, et al Risk factors for epilepsy in Bas-Uele Province, Democratic Republic of the Congo: A case-control study. Int J Infect Dis 2016; 49: 1– 8 27210267 PMC4973807
  22. [22]Golden A, Faulx D, Kalnoky M, et al Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit Vectors 2016; 9: 338 27296630 PMC4907250
  23. [23]Zimmerman PA, Guderian RH, Aruajo E, et al Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: Improved detection of patients with onchocerciasis. J Infect Dis 1994; 169: 686– 9 8158053
  24. [24]Foger K, Gora-Stahlberg G, Sejvar J, et al Nakalanga syndrome: clinical characteristics, potential causes, and its relationship with recently described Nodding syndrome. PLoS Negl Trop Dis 2017; 11: e0005201 28182652 PMC5300103
  25. [25]Huberfeld G, Blauwblomme T, Miles R. Hippocampus and epilepsy: Findings from human tissues. Rev Neurol (Paris) 2015; 171: 236– 51 25724711 PMC4409112
  26. [26]Colebunders R, Abd-Elfarag G, Carter JY, et al Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan. Seizure 2018; 62: 108– 15 30340162
  27. [27]Braak H, Thal DR, Ghebremedhin E, et al Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70: 960– 9 22002422
  28. [28]Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull 2016; 126: 238– 92 27615390
  29. [31]Wong KT, Allen IV, McQuaid S, et al An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic Parkinsonism. Clin Neuropathol 1996; 15: 22– 5 8998852
  30. [32]Tai XY, Koepp M, Duncan JS, et al Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: A study of temporal lobe resections. Brain 2016; 139: 2441– 55 27497924 PMC5926008
  31. [33]Tabaton M, Mandybur TI, Perry G, et al The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol 1989; 26: 771– 8 2557796
  32. [34]Williams DR. Tauopathies: Classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 2006; 36: 652– 60 16958643
  33. [35]Ling H, Holton JL, Lees AJ, et al TDP-43 pathology is present in most post-encephalitic parkinsonism brains. Neuropathol Appl Neurobiol 2014; 40: 654– 7 23763789

Cited by

Sorted by citations

Authors
Hotterbeekx, A., Lammens, M., Idro, R., Akun, P. R., Lukande, R., Akena, G., Nath, A., Taylor, J., Olwa, F., Kumar-Singh, S., & Colebunders, R.
Affiliations
  • University of Antwerp (BE)
  • Antwerp University Hospital (BE)
  • Makerere University (UG)
  • Kitgum Hospital, Kitgum, Uganda
  • National Institutes of Health (US)
  • Department of Forensic Medicine, New York University, School of Medicine, New York City Office of the Chief Medical Examiner, New York, New York
  • Lira University (UG)
  • Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Corresponding author
Hotterbeekx, An
Venue
Journal of Neuropathology & Experimental Neurology
Published
2019-09-06
Volume
78
Issue
11
Pages
1049-1058
ISSN
  • 0022-3069 (ISSN-L)
  • 1554-6578
OpenAlex
W2976552244
Cited by
54
References
2
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 3
FWCI
7.67
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuropathology & Experimental Neurology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
European Research Council (NSETHIO 671055)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
nodding syndrome, onchocerciasis-associated epilepsy, neuroinflammation, tauopathy, neurofibrillary tangles, cerebellar atrophy, Purkinje cells, Bergmann glia, gliosis, macrophages, ventriculitis, meningitis, pediatric epilepsy, Northern Uganda
MeSH terms
Adolescent, Adult, Brain, Encephalitis, Female, Humans, Male, Onchocerciasis, Uganda, Neurofibrillary Tangles, Tauopathies, Young Adult, Nodding Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review